Full Breakdown
Trump’s “Reverse Surgery” Claim Amid a Federal Push That Limits Transgender Care
8/25/2026, 11:59:53 AM
Core Event
At a rally on Aug. 21 in Myrtle Beach, South Carolina, former President Donald Trump asserted that hospitals were performing “reverse surgery” on transgender patients “at my order.” No medical procedure by that name exists. The statement coincided with a broader federal campaign that uses funding rules, investigations, and settlement agreements to pressure hospitals and clinicians to curtail gender-affirming care for minors.
Background & Context
Since early 2024, the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) have finalized a rule ending federal Medicaid payments for specified gender-affirming procedures for patients under 18 and cutting Children’s Health Insurance Program (CHIP) funding for patients under 19. The rule takes effect on October 13, with a six-month transition that allows limited continued funding for patients already on hormone therapy.
The Justice Department (DOJ) has pursued agreements with major hospital systems. Texas Children’s Hospital agreed to cease gender-affirming care for minors, pay a $10 million settlement, and establish a “restorative care” clinic for detransitioners. The Cleveland Clinic entered a settlement that includes $2 million for detransition services and a pledge to refrain from most gender-affirming care for minors for two decades. Both hospitals described the agreements as moves to avoid costly litigation rather than admissions of wrongdoing.
Data & Statistics
- The CMS rule, scheduled for October 13, will stop Medicaid and CHIP payments for gender-affirming procedures for minors, while permitting limited funding for up to six months for patients tapering off hormones.
- Texas Children’s Hospital’s settlement includes a $10 million payment; the Cleveland Clinic’s settlement involves $2 million for detransition services and a $308 000 payment to resolve billing allegations.
Official Statements & Responses
- HHS officials framed the rule as a measure to ensure federal funds are used for “medically necessary” services, citing concerns about long-term outcomes of puberty blockers and hormone therapy for minors.
- DOJ representatives described the hospital agreements as “necessary steps” to address alleged billing irregularities and to protect federal resources.
- A federal judge in California blocked a court order seeking medical records from Lucile Packard Children’s Hospital, emphasizing patient privacy.
- Hospital leaders, such as the chief medical officer of Callen-Lorde Community Health Center, reiterated that medical decisions should remain between providers, patients, and families, rejecting any notion of presidential directives dictating clinical care.
Criticism & Opposition
- Dr. [Name omitted for brevity] criticized the politicization of care.
- Dr. [Name omitted for brevity] warned that the rule could disrupt continuity of treatment for youth already in care.
Conflicting Reports & Gaps
- Trump’s “reverse surgery” claim suggests hospitals are performing procedures to undo prior gender-affirming surgeries. No evidence or medical definition supports the existence of such a mandated procedure.
- A 2024 JAMA Network Open study of nearly 23 million minors found virtually no gender-affirming surgeries among children 12 or younger and a rate of 0.1 per 100 000 for ages 13-14, indicating that the alleged widespread “reverse surgeries” are not reflected in national data.
What’s Next
The CMS rule will become operative on October 13, initiating the cessation of federal funding for most gender-affirming procedures for minors. Hospitals that have entered settlement agreements are expected to implement the terms of those deals over the coming months, while ongoing litigation may further shape the availability of transgender health services.
